Noninvasive assessment of airway inflammation in children: Induced sputum, exhaled nitric oxide, and breath condensate

European Respiratory Journal

Volumn 16, Issue 5, 2000, Pages 1008-1015

  Gibson, P G ^a   Henry, R L ^a   Thomas, P ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Airway inflammation; Childhood asthma; Exhaled breath analysis; Sputum eosinophilia

Indexed keywords

NITRIC OXIDE;

ARTICLE; ASTHMA; BREATH ANALYSIS; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC VALUE; HUMAN; INFLAMMATORY DISEASE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

BREATH TESTS; BRONCHITIS; CHILD, PRESCHOOL; HUMANS; NITRIC OXIDE; RESPIRATION; SPUTUM;

EID: 0034521171     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Use of induced sputum cell counts to investigate airway inflammation in asthma
2. Effect of tidal volume on the output and particle size distribution of hypertonic saline from an ultrasonic nebulizer
3. Inhalation provocation tests using non-isotonic aerosols
4. Salbutamol pretreatment does not change eosinophil percentage and eosinophilic cationic protein concentration in hypertonic saline-induced sputum in asthmatic subjects
5. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood
6. Assessment of airways inflammation in children with acute asthma using induced sputum
7. Influence of allergen avoidance on the eosinophilic phase of airway inflammation in children with allergic asthma
8. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children
9. Chemotherapy for malignancy induces a remission in asthma symptoms and airway inflammation but not airway hyperresponsiveness
10. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
11. Mite-allergen avoidance can reduce bronchial epithelial shedding in allergic asthmatic children
12. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma
13. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children
14. Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust
15. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma
16. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophilic cationic protein to clinical severity
17. Pattern of airway inflammation and its determinants in children with severe asthma
18. IL-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma
19. Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation
20. Terfenadine modifies airway narrowing induced by the inhalation of nonisotonic aerosols in subjects with asthma
21. Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permanent anion causes cough alone
22. Methods of examining induced sputum: Do differences matter?
23. Cellular characteristics of sputum from patients with asthma and chronic bronchitis
24. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
25. Comparison of two methods of processing induced sputum: Selected versus entire sputum
26. Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness
27. The effects of salivary contamination on sputum cell counts: Establishing quality criteria
28. Comparison of inflammatory cell counts in asthma: Induced sputum vs bronchoalveolar lavage and bronchial biopsies
29. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: Inflammatory cells, lymphocyte subsets and soluble markers compared
30. Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood
31. The eosinophil and the pathophysiology of asthma
32. Comparison of sputum processing techniques in cystic fibrosis
33. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis
34. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis
35. The role of recombinant human DNase in the treatment of patients with cystic fibrosis: Many promises, more problems
36. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference
37. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
38. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans
39. Single-breath nitric oxide measurements in asthmatic patients and smokers
40. Increased nitric oxide in exhaled air of asthmatic patients
41. Exhaled nitric oxide in pediatric asthma and cystic fibrosis
42. Expired nitric oxide as a marker for childhood asthma
43. Corticosteroids decrease exhaled nitric oxide in children with acute asthma
44. Exhaled nitric oxide levels in normal and asthmatic children
45. Exhaled and nasal nitric oxide measurements: Recommendations. The European Respiratory Society Task Force
46. ATS statement. Recommendations for standardised procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children 1999
47. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticosteroids in children
48. Measurements of exhaled nitric oxide with the single breath technique and positive expiratory pressure in infants
49. Exhaled nitric oxide in childhood asthma
50. Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis
51. Exhaled nitric oxide in preterm infants
52. Measurement of expired nitric oxide levels in children
53. Reference values of exhaled nitric oxide in healthy children 6-15 years old
54. A community study of exhaled nitric oxide in healthy children
55. The elevated level of exhaled nitric oxide is mainly derived from the lower respiratory tract
56. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma
57. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
58. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide
59. Increased nitric oxide in exhaled air of normal subjects with upper respiratory tract infections
60. Influenza vaccination: Changes in exhaled nitric oxide and sputum cytology
61. Relationship between exhaled nitric oxide and childhood asthma
62. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children
63. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients
64. Hydrogen peroxide in exhaled air of healthy children: Reference values
65. Hydrogen peroxide in exhaled air is increased in stable asthmatic children